Abstract
The use of dendritic cells to immunize against tumor antigens is improving the prospects for cancer vaccines. However, caution must be taken to avoid activating autoimmunity against normal cells (pages 1011-1017).
| Original language | English (US) |
|---|---|
| Pages (from-to) | 966-968 |
| Number of pages | 3 |
| Journal | Nature medicine |
| Volume | 6 |
| Issue number | 9 |
| DOIs | |
| State | Published - Sep 2000 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology